Mesoblast Reports Financial Results and Corporate Highlights for First Half Ended December 31, 2019

    NEXT STORY
    ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
    PREV STORY
    Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Basilea announces closing of previously announced transaction regarding divestment of its Chinese R&D subsidiary

    author_avatar
    NASDAQ Market News

    ASTRAZENECA’S FASLODEX MET PRIMARY ENDPOINT IN FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER

    AstraZeneca today announced positive results from the Phase III FALCON trial comparing Faslodex 500mg ...

    author_avatar
    NASDAQ Market News

    MINNEAPOLIS-BASED MEDICAL SOFTWARE COMPANY, PROVATION, NAMES NEW CHIEF TECHNOLOGY OFFICER

    author_avatar
    NASDAQ Market News